Zobrazeno 1 - 10
of 10
pro vyhledávání: '"MIHAI DODOT"'
Autor:
Irina Duport-Dodot, Catalin Tiliscan, Mihaela Radulescu, Anca Saran, Laurentiu Stratan, Anca Negru, Nicoleta Mihai, Mihai Dodot, Alexandru Croitoru, Victoria Arama, Stefan Sorin Arama
Publikováno v:
Romanian Journal of Infectious Diseases, Vol 26, Iss 2, Pp 73-78 (2023)
Although Hepatitis C virus (HCV) infection has become a curable disease, the aftermath of the infection remains an important aspect to be evaluated. HCV infection is well known for its extrahepatic manifestations, mostly the tight relationship betwe
Externí odkaz:
https://doaj.org/article/d2615a572184483b9c817122167e4897
Autor:
GABRIELA DROC, MIRCEA ISTRATE, ADRIANA MERCAN-STANCIU, MIHAI DODOT, TEODORA ISAC, LETITIA TOMA, ANCA ZGURA, ANCA TRIFAN, ANDREEA NICOLETA SERBANICA, LAURA ILIESCU, LAURENTIU MICU
Publikováno v:
In Vivo
Background/Aim: The aim of this study was to determine the safety and efficacy of a direct-acting antiviral treatment, ombitasvir/paritaprevir/ritonavir and dasabuvir, without ribavirin, in a real-life setting. Patients and Methods: We performed a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::200b21b3e540efba20cb4fb8bab11378
https://doi.org/10.21873/invivo.13033
https://doi.org/10.21873/invivo.13033
Autor:
Gabriel Cristian Popescu, Razvan Rababoc, Adriana Mercan-Stanciu, Mihai Dodot, Teodora Isac, Letitia Toma, Anca Zgura, Anca Trifan, Andreea Nicoleta Serbanica, Laurentiu Micu, Laura Iliescu
Publikováno v:
Archiv Euromedica. 12
Aim: The aim of this study is to assess the evolution of Fibromax® parameters (fibrosis, inflammation, steatosis, steatohepatitis) in patients with chronic HCV hepatitis at one year after sustained virologic response (SVR) achieved by direct acting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87b615b3b8ce5ccbcad66c750b5ca646
https://doi.org/10.35630/2022/12/6.16
https://doi.org/10.35630/2022/12/6.16
Autor:
Andrei Silaghi, Nicolae Bacalbasa, Mihai Dodot, Letitia Toma, Anca Zgura, Razvan Simu, Teodora Isac, Adriana Mercan-Stanciu
Publikováno v:
Clinical and Experimental Medicine
This study aims to evaluate differences in serum and fecal calprotectin in patients with HCV chronic hepatitis and COVID-19 infection and compare them to a control group. This observational study was performed between April 2020 and October 2020 in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f8540536e6d4247aa78236c5baa820
http://europepmc.org/articles/PMC8274470
http://europepmc.org/articles/PMC8274470
Autor:
Adriana Mercan-Stanciu, Anca Zgura, Nicolae Bacalbasa, Daniel Rusie, Dumitru Cristinel Badiu, Letitia Toma, Mihai Dodot, Teodora Isac, Bogdan Haineala, Elena Laura Iliescu, Silviu S Guler-Margaritis, Dragos Serban
Publikováno v:
In Vivo
Background/aim Liver injury has been frequently reported in association with SARS-CoV-2 infection, but data are still lacking regarding the impact of pre-existing liver damage and neoplasia on SARS-CoV-2 infection outcome and vice-versa. This study a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f5fb54aa1842cd1a3444377dbb727d
https://doi.org/10.21873/invivo.12636
https://doi.org/10.21873/invivo.12636
Publikováno v:
Modern Medicine, Vol 27, Iss 1, Pp 11-18 (2020)
Chronic hepatitis B still represents a major challenge for clinicians and the public health service even years after the development of an efficient vaccine and potent antiviral agents. The major actual problems in treating chronic hepatitis B (HBV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caacc84c9d1bff1dd31948d5f9f58c92
https://doi.org/10.31689/rmm.2020.27.1.11
https://doi.org/10.31689/rmm.2020.27.1.11
Autor:
Letitia Toma, Mihai Dodot, Anca Zgura, Nicolae Bacalbasa, Andrei Silaghi, Razvan Simu, Teodora Isac, Adriana Mercan Stanciu
PurposeThis study aims to evaluate differences in serum and fecal calprotectin in patients with HCV chronic hepatitis and COVID-19 infection and compare them to a control group. MethodsThis observational study was performed between April 2020 and Oct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb05bd2e3a50e8dc945cb5fbebd36a5d
https://doi.org/10.21203/rs.3.rs-497871/v1
https://doi.org/10.21203/rs.3.rs-497871/v1
Autor:
Mugur Grasu, Adriana Mercan-Stanciu, Alexandru Martiniuc, Xenia Bacinschi, Bogdan Haineala, Rodica Anghel, Vlad Herlea, Letitia Toma, Mihai Dodot, Anca Zgura
Publikováno v:
Cancer Diagn Progn
Background/Aim: Fibrolamellar carcinoma is a rare primary hepatic malignancy that has recently been recognized as a distinct clinical entity, highly different from the well-known hepatocellular carcinoma. This report describes the clinical and paracl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3cbeca4c1ef23b2b5d1e7bce9385f3
https://europepmc.org/articles/PMC8962773/
https://europepmc.org/articles/PMC8962773/
Autor:
Mihai Dodot, Adriana Mercan-Stanciu, Laura Iliescu, Letitia Toma, Teodora Isac, Mihaela Grumeza, Simona Ioanitescu
Publikováno v:
Medical ultrasonography. 21(3)
Budd Chiari syndrome defines an obstruction of the hepatic venous outflow. Primary causes include pro-coagulant states resulting in venous thrombosis, while secondary Budd Chiari syndrome appears in conditions associated with extrinsic compression of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1242a5d6a4b222cbe4d671effd169160
https://pubmed.ncbi.nlm.nih.gov/31476215
https://pubmed.ncbi.nlm.nih.gov/31476215
Autor:
Adriana Mercan, Elena Laura Iliescu, Mihai Dodot, Mihaela Grumeza, Teodora Isac, Letitia Toma
Publikováno v:
Gastroenterology. 156:S-1232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77788ee5a10817558b4d6d8be4d9a0bf
https://doi.org/10.1016/s0016-5085(19)40074-7
https://doi.org/10.1016/s0016-5085(19)40074-7